71773-100-12 |
71773-100 |
HUMAN PRESCRIPTION DRUG |
Xerava |
eravacycline |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20200914 |
N/A |
NDA |
NDA211109 |
Tetraphase Pharmaceuticals, Inc. |
ERAVACYCLINE DIHYDROCHLORIDE |
100 mg/1 |
12 CARTON in 1 PACKAGE (71773-100-12) / 1 VIAL, GLASS in 1 CARTON (71773-100-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
71773-050-12 |
71773-050 |
HUMAN PRESCRIPTION DRUG |
Xerava |
eravacycline |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180910 |
N/A |
NDA |
NDA211109 |
Tetraphase Pharmaceuticals, Inc. |
ERAVACYCLINE DIHYDROCHLORIDE |
50 mg/1 |
12 VIAL, GLASS in 1 CARTON (71773-050-12) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
71773-050-05 |
71773-050 |
HUMAN PRESCRIPTION DRUG |
Xerava |
eravacycline |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180910 |
N/A |
NDA |
NDA211109 |
Tetraphase Pharmaceuticals, Inc. |
ERAVACYCLINE DIHYDROCHLORIDE |
50 mg/1 |
1 VIAL, GLASS in 1 CARTON (71773-050-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |